| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | PANTOPRAZOLE | 2 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 |
| 3 | AMIKACIN | 1 |
| 4 | BEVACIZUMAB | 1 |
| 5 | BUPROPION HYDROCHLORIDE | 1 |
| 6 | CARBOPLATIN | 1 |
| 7 | CEFOXITIN | 1 |
| 8 | CEFOXITIN SODIUM | 1 |
| 9 | CLARITHROMYCIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 1 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 3 | AMIKACIN | 1 | 0.0001 |
| 4 | CLARITHROMYCIN | 1 | 0.0000 |
| 5 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 6 | DOCETAXEL ANHYDROUS | 1 | 0.0000 |
| 7 | DOCETAXEL | 1 | 0.0000 |
| 8 | TRASTUZUMAB | 1 | 0.0000 |
| 9 | VEDOLIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Interferon beta [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 1 | 0.0000 |